NCT00375843View on ClinicalTrials.gov

Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication

PHASE4CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

March 31, 2008

Conditions
Depression
Interventions
DRUG

Escitalopram

Level 1 of the study involves open-label treatment with escitalopram, up to 30 mg/day for up to 12 weeks.

DRUG

Sertraline

Level 2 of the study involves open-label treatment with sertraline, up to 200 mg/day for up to 12 weeks.

Trial Locations (3)

90095

UCLA Semel Institute, Los Angeles

90502

Harbor-UCLA Medical Center, Torrance

02114

Harvard/MGH, Boston

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH

NCT00375843 - Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication | Biotech Hunter | Biotech Hunter